Can't disagree with anyone's concerns. Some disappointment, nothing exciting since NGIO spinoff. Not much different than action in any other biotech on OTC. However, still fewer than 75K shares traded.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
